These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9662124

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
    Mercapide J, Lopez De Cicco R, Castresana JS, Klein-Szanto AJ.
    Int J Cancer; 2003 Sep 20; 106(5):676-82. PubMed ID: 12866026
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes.
    Tanigawa S, Aida Y, Kawato T, Honda K, Nakayama G, Motohashi M, Suzuki N, Ochiai K, Matsumura H, Maeno M.
    Cytokine; 2011 Nov 20; 56(2):376-86. PubMed ID: 21885294
    [Abstract] [Full Text] [Related]

  • 24. Matrix metalloproteinases and TIMP-1 localization at sites of osteogenesis in the craniofacial region of the rabbit embryo.
    Breckon JJ, Hembry RM, Reynolds JJ, Meikle MC.
    Anat Rec; 1995 Jun 20; 242(2):177-87. PubMed ID: 7668402
    [Abstract] [Full Text] [Related]

  • 25. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
    Liu Z, Ivanoff A, Klominek J.
    Int J Cancer; 2001 Mar 01; 91(5):638-43. PubMed ID: 11267973
    [Abstract] [Full Text] [Related]

  • 26. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
    Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, Suda T.
    Endocrinology; 1998 Mar 01; 139(3):1338-45. PubMed ID: 9492070
    [Abstract] [Full Text] [Related]

  • 27. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
    Maeda S, Dean DD, Gay I, Schwartz Z, Boyan BD.
    J Bone Miner Res; 2001 Jul 01; 16(7):1281-90. PubMed ID: 11450704
    [Abstract] [Full Text] [Related]

  • 28. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y.
    Lab Invest; 1995 Dec 01; 73(6):899-911. PubMed ID: 8558853
    [Abstract] [Full Text] [Related]

  • 29. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S, Dean DD, Gomez R, Schwartz Z, Boyan BD.
    Calcif Tissue Int; 2002 Jan 01; 70(1):54-65. PubMed ID: 11907708
    [Abstract] [Full Text] [Related]

  • 30. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G, Walter I, Helmreich M, Egerbacher M.
    Calcif Tissue Int; 2005 May 01; 76(5):326-35. PubMed ID: 15868281
    [Abstract] [Full Text] [Related]

  • 31. An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1).
    Qin X, Chua PK, Ohira RH, Bryant-Greenwood GD.
    Biol Reprod; 1997 Apr 01; 56(4):812-20. PubMed ID: 9096860
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
    Galis ZS, Sukhova GK, Lark MW, Libby P.
    J Clin Invest; 1994 Dec 01; 94(6):2493-503. PubMed ID: 7989608
    [Abstract] [Full Text] [Related]

  • 34. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 01; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes.
    Fortunato SJ, Menon R, Lombardi SJ.
    Obstet Gynecol; 1999 Sep 01; 94(3):435-40. PubMed ID: 10472874
    [Abstract] [Full Text] [Related]

  • 37. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D.
    Am J Pathol; 1997 Feb 01; 150(2):653-66. PubMed ID: 9033278
    [Abstract] [Full Text] [Related]

  • 38. Expression and purification of human stromelysin 1 and 3 from baculovirus-infected insect cells.
    del Mar Barbacid M, Fernández-Resa P, Buesa JM, Márquez G, Aracil M, Quesadaand AR, Mira E.
    Protein Expr Purif; 1998 Jul 01; 13(2):243-50. PubMed ID: 9675069
    [Abstract] [Full Text] [Related]

  • 39. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP.
    Invasion Metastasis; 1992 Jul 01; 12(3-4):168-84. PubMed ID: 1284126
    [Abstract] [Full Text] [Related]

  • 40. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
    Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M.
    Lab Invest; 1995 Mar 01; 72(3):311-22. PubMed ID: 7898050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.